肺功能参数与急性山病有关,并且在高空和极端高度改善
Reto Reiser1, Anne-Kathrin Brill1, Christos T Nakas2
1Department of Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Respiratory physiology & neurobiology
|August 25, 2024
概括
高海拔暴露改善了肺功能,峰值呼气流 (PEF) 显示与适应适应. 较低的基线PEF和FEV1与急性山病 (AMS) 风险有关,但与峰会成功无关.
科学领域:
- 生理学 生理学 生理学
- 高度医学 高度医学
背景情况:
- 高海拔环境带来生理挑战,包括降低气压和温度.
- 适应气候对于适应这些条件至关重要,可能会影响呼吸功能.
研究的目的:
- 评估高空暴露和适应对肺功能的影响.
- 为了确定肺功能是否与急性山病 (AMS) 和峰会成功有关.
主要方法:
- 在高海拔探险期间,39名受试者接受了重复的螺旋测量,高达6022米.
- 根据AMS发生情况和峰会成功情况对主题进行了分类.
主要成果:
- 肺功能参数,包括峰值呼气流 (PEF),强迫生命能力 (FVC) 和1秒内强迫呼气体积 (FEV1),随着高度的增加而增加.
- 只有PEF显示与适应改善.
- 在患有AMS的受试者中观察到较低的FEV1和海拔高度的PEF.
- 较低的基线PEF和PEF和FEV1的变化与AMS风险相关.
- 肺功能与登顶成功没有相关性.
结论:
- 肺功能通常会随着高度的增加而改善,PEF显示适应适应.
- 以前存在或发展较低的PEF和FEV1可能表明AMS的风险较高.
- 肺功能似乎不是在这些高度上成功登顶的限制因素.
相关概念视频
Factors Affecting Respiration
4.9K
Respiration is a crucial physiological function involving exchanging oxygen (O2) and carbon dioxide (CO2) between an organism and its environment. Various factors can impact this essential process:
4.9K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Acute Respiratory Failure-III
165
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
165
Acute Respiratory Failure-IV
132
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
132
COPD: Management Using Bronchodilators and Corticosteroids
190
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
190
Acute Respiratory Failure-II
187
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
187


